Drugs / 18F-TPP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07506616 | Jun 2026 → Aug 2033 expected | — | Yale University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-TPP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07506616 ↗ |
| Modality | Diagnostic / imaging agent | “radiotracer specific for imaging mitochondrial membrane potential (ΔΨm)” NCT07506616 ↗ |
| Route | Intravenous | “administered intravenously” NCT07506616 ↗ |